ABOUT US

Passion, Creativity and Challenge, Global No.1 Healthcare Company

History

  • 2020
    • 09

      The first development of Remdesivir nationwide and technology transfer of Remdesivir to Indonesia

  • 2019
    • 08

      License-out of new drug candidates of Lactobacillus Bacillus to Myungmoon Pharmaceutical Co., Ltd.

    • 05

      The Yesan Plant certified as large synthetic unit by KFDA

  • 2018
    • 05

      The Jonint Venture plant for API in Indoneisa certified as GMP by PICS

    • 05

      The Yesan Plant certified as GMP by KFDA

    • 01

      Completion of the Jonint Venture Plant in Indonesia for API

  • 2017
    • 12

      Received 3 Million US Dollar Export Monument Award

    • 04

      The Yesan Plant Licensed as a Drug Manufacturer Plant

  • 2016
    • 12

      Recived One-Million-Dollar Export Monument Award

    • 11

      Completion of Yesan Plant

  • 2015
    • 12

      Established Joint Venture with PT. Kimia Farma (Cepharlosporiium fermentation & API Plant)

    • 08

      Signed Joint Venture MOU with PT. Kimia Farma

  • 2014
    • 07

      Took over KPX Biotech and Changed the name to Sungwun Bio Inc.

  • 2013
    • 03

      Dietary supplements sales business and venture manufacturing business authorized

  • 2012
    • 03

      Certified as INNO-BIZ

  • 2011
    • 06

      Venture Business Verification Certification

  • 2008
    • 07

      Establishment of R&D Center

  • 2007
    • 02

      Establishment of Sungwun Pharmacopia Co., Ltd. (Bio & Synthesis R&D company)